These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7579055)

  • 1. Expression and preferential inhibition of inducible nitric oxide synthase in aortas of endotoxemic rats.
    Weigert AL; Higa EM; Niederberger M; McMurtry IF; Raynolds M; Schrier RW
    J Am Soc Nephrol; 1995 Jun; 5(12):2067-72. PubMed ID: 7579055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inducible nitric oxide synthase and vascular reactivity in rat thoracic aorta: effect of aminoguanidine.
    Scott JA; Machoun M; McCormack DG
    J Appl Physiol (1985); 1996 Jan; 80(1):271-7. PubMed ID: 8847314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelium-dependent vascular hyporesponsiveness without detection of nitric oxide synthase induction in aortas of cirrhotic rats.
    Weigert AL; Martin PY; Niederberger M; Higa EM; McMurtry IF; Gines P; Schrier RW
    Hepatology; 1995 Dec; 22(6):1856-62. PubMed ID: 7489998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform.
    Szabó C; Bryk R; Zingarelli B; Southan GJ; Gahman TC; Bhat V; Salzman AL; Wolff DJ
    Br J Pharmacol; 1996 Aug; 118(7):1659-68. PubMed ID: 8842429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoguanidine reverses aortic hyporeactivity to noradrenaline in portal vein-ligated rats.
    Michielsen PP; Boeckxstaens GE; Sys SU; Herman AG; Pelckmans PA
    Eur J Pharmacol; 1997 Jun; 329(2-3):137-46. PubMed ID: 9226406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoguanidine selectively decreases cyclic GMP levels produced by inducible nitric oxide synthase.
    Griffiths MJ; Messent M; Curzen NP; Evans TW
    Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1599-604. PubMed ID: 7582301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the effects of two new arginine/citrulline analogues on constitutive and inducible nitric oxide synthases in rat aorta.
    Joly GA; Narayanan K; Griffith OW; Kilbourn RG
    Br J Pharmacol; 1995 Jun; 115(3):491-7. PubMed ID: 7582462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginsenoside Rg3 inhibits phenylephrine-induced vascular contraction through induction of nitric oxide synthase.
    Kim ND; Kim EM; Kang KW; Cho MK; Choi SY; Kim SG
    Br J Pharmacol; 2003 Oct; 140(4):661-70. PubMed ID: 14534150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terlipressin inhibits in vivo aortic iNOS expression induced by lipopolysaccharide in rats with biliary cirrhosis.
    Moreau R; Barrière E; Tazi KA; Lardeux B; Dargère D; Urbanowicz W; Poirel O; Chauvelot-Moachon L; Guimont MC; Bernuau D; Lebrec D
    Hepatology; 2002 Nov; 36(5):1070-8. PubMed ID: 12395316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. autoregulatory role of endothelium-derived nitric oxide (NO) on Lipopolysaccharide-induced vascular inducible NO synthase expression and function.
    Vo PA; Lad B; Tomlinson JA; Francis S; Ahluwalia A
    J Biol Chem; 2005 Feb; 280(8):7236-43. PubMed ID: 15583003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of excess tetrahydrobiopterin during nitric oxide production from inducible nitric oxide synthase in LPS-treated rat aorta.
    Shimizu S; Ishii M; Kawakami Y; Kiuchi Y; Momose K; Yamamoto T
    Life Sci; 1999; 65(26):2769-79. PubMed ID: 10622266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of inducible nitric oxide synthase by beta-lapachone in rat alveolar macrophages and aorta.
    Liu SH; Tzeng HP; Kuo ML; Lin-Shiau SY
    Br J Pharmacol; 1999 Feb; 126(3):746-50. PubMed ID: 10188987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two new nitric oxide synthase inhibitors: pyridoxal aminoguanidine and 8-quinolinecarboxylic hydrazide selectively inhibit basal but not agonist-stimulated release of nitric oxide in rat aorta.
    Pekiner C; Kelicen P; Uma S; Miwa I
    Pharmacol Res; 2002 Oct; 46(4):317-20. PubMed ID: 12361692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a novel guanylyl cyclase inhibitor on the vascular actions of nitric oxide and peroxynitrite in immunostimulated smooth muscle cells and in endotoxic shock.
    Zingarelli B; Haskó G; Salzman AL; Szabó C
    Crit Care Med; 1999 Sep; 27(9):1701-7. PubMed ID: 10507586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide-independent activation of soluble guanylyl cyclase contributes to endotoxin shock in rats.
    Wu CC; Chen SJ; Yen MH
    Am J Physiol; 1998 Oct; 275(4):H1148-57. PubMed ID: 9746461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyporesponsiveness to Ca2+ of aortic smooth muscle in endotoxin-treated rats: no-dependent and -independent in vitro mechanisms.
    Ho KH; Kwan CY; Bourreau JP
    Res Commun Mol Pathol Pharmacol; 1996 Jun; 92(3):275-84. PubMed ID: 8827826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of nitric oxide synthase by endotoxin in rat isolated aorta but not in rat aortic smooth muscle cells grown in culture from explant.
    McKendrick JD; Paisley K; Eason S; Mian KB; Martin W
    Arch Int Pharmacodyn Ther; 1995; 330(2):206-24. PubMed ID: 8861713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of human cathelicidin antimicrobial peptide LL-37 on lipopolysaccharide-induced nitric oxide release from rat aorta in vitro.
    Ciornei CD; Egesten A; Bodelsson M
    Acta Anaesthesiol Scand; 2003 Feb; 47(2):213-20. PubMed ID: 12631052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboxane A2 regulates vascular tone via its inhibitory effect on the expression of inducible nitric oxide synthase.
    Yamada T; Fujino T; Yuhki K; Hara A; Karibe H; Takahata O; Okada Y; Xiao CY; Takayama K; Kuriyama S; Taniguchi T; Shiokoshi T; Ohsaki Y; Kikuchi K; Narumiya S; Ushikubi F
    Circulation; 2003 Nov; 108(19):2381-6. PubMed ID: 14557367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of the expression of inducible nitric oxide synthase by a novel positive inotropic agent, YS 49, in rat vascular smooth muscle and RAW 264.7 macrophages.
    Kang YJ; Koo EB; Lee YS; Yun-Choi HS; Chang KC
    Br J Pharmacol; 1999 Sep; 128(2):357-64. PubMed ID: 10510445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.